The effect of clinical decision making for initiation of systemic anticancer treatments in response to the COVID-19 pandemic in England: a retrospective analysis

Findings note 32% reduction in anticancer treatment initiation after onset of pandemic (April 2020) vs control period (Sept 2019-Feb 2020; p<0.0001). However, treatment initiation increased in May 2020 (10% reduction) and June 2020 (15% increase) vs control period (both p<0.0001)

The Lancet Oncology